Exscientia AI Limited
Oxford, United Kingdom
Purpose
to rapidly discover and develop potent, orally available, small molecule inhibitors of the main protease (Mpro) of SARS-CoV-2 using artificial intelligence-driven structure guided drug design
Division
Global Health
Date
June 2021
Region Served
GLOBAL
Committed amount
$767,100
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
4
Grantee location
Oxford, United Kingdom
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.